Immunoconjugates with an intracellularly-cleavable linkage

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE48751
SERIAL NO

16218384

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNOMEDICS INC300 AMERICAN ROAD MORRIS PLAINS NJ 07950

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goldenberg, David M Mendham, US 527 13665
Govindan, Serengulam V Summit, US 138 3073
Moon, Sung-Ju New Providence, US 31 1294

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 28, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 28, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 28, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00